Nom du produit:3-[4-(4-hydroxybutylamino)-1-oxo-isoindolin-2-yl]piperidine-2,6-dione
IUPAC Name:3-{4-[(4-hydroxybutyl)amino]-1-oxo-2,3-dihydro-1H-isoindol-2-yl}piperidine-2,6-dione
- CAS：2940935-25-9
- Formule moléculaire：C17H21N3O4
- Pureté：95%
- Numéro de catalogue：CM1077498
- Poids moléculaire：331.37
| Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:2940935-25-9
- Formule moléculaire:C17H21N3O4
- Point de fusion:-
- Code SMILES:OCCCCNC1=C2CN(C3CCC(=O)NC3=O)C(=O)C2=CC=C1
- Densité:
- Numéro de catalogue:CM1077498
- Poids moléculaire:331.37
- Point d'ébullition:
- N° Mdl:
- Stockage:
Category Infos
- PROTAC-E3 Ligase Ligands
- Bifunctional degrader molecules, also called proteolysis-targeting chimeras (PROTACs), are a new modality of chemical tools and potential therapeutics to understand and treat human disease. A required PROTAC component is a ligand binding to an E3 ubiquitin ligase, which is then joined to another ligand binding to a protein to be degraded via the ubiquitin–proteasome system. The advent of nonpeptidic small-molecule E3 ligase ligands revolutionized the field and ushered in the design of drug-like PROTACs with potent and selective degradation activity.
- PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- Proteolysis-Targeting Chimeras | PROTAC-E3 Ligase Ligands | PROTACs | Bifunctional Degrader Molecules
- PROTAC (Proteolysis-Targeting Chimeras) is a promising approach in drug discovery that involves the use of small molecules to target specific proteins for degradation by the cellular machinery.
Recherche 
+86 21 5895 0110 
